Jan 6 (Reuters) - CannPal Animal Therapeutics Ltd (CP1) : GOT EXCLUSIVE GLOBAL RIGHTS TO COMMERCIALISE MICROMAX MICROENCAPSULATION TECHNOLOGY BY CSIRO FOR ANIMAL THERAPEUTICS USE
Webinar: What investors should know about what it takes for ASX-listed companies to get medical developments to market